Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 103Poisoning and overdose treatmentsSexual function and dysfunction studiesForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Recreational Use and Misuse of Phosphodiesterase 5 Inhibitors

Smith, Kelly M., Romanelli, Frank·2005·Journal of the American Pharmacists Association
DOI 10.1331/1544345052843165
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1331/1544345052843165

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 40 references

Research works printed but not linked: 11

  1. Hussar, 2003, The phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction, Drug Advisor, 2, 1
  2. Burke, 2003, Prescription drugs on the Internet, Pharm Times, 69, 68
  3. Berry, 2004, Thousands of British men buying fake ED drug, Pharm Today, 10, 26
  4. Anonymous, 2004, FDA raid blocks counterfeit Viagra, US Pharm., 29, 35
  5. Ward, 1999, Letter re: the pathophysiology and ICU treatment of patients following the use of ecstasy [letter], Br J Intensive Care., 9, 196
  6. Downie, 2000, The abuse and misuse of prescribed and over-the-counter medicines, Hosp Pharm., 7, 242
  7. James, 1998, Viagra warning regarding “poppers” and protease inhibitors, AIDS Treat News., 294, 1
  8. Posey, 2003, Options grow for patients with erectile dysfunction: FDA approves vardenafil, Pharm Today, 9, 5
  9. Siegel, 2003, Letter to the editor, Hum Exp Toxicol., 22, 463
  10. Solomon, 2002, Viagra on the Internet: unsafe sexual practice, Int J Clin Pract., 56, 403, 10.1111/j.1742-1241.2002.tb11284.x · DOI
  11. Editorial Staff. Sildenafil and related agents (management/treatment protocol). In: Toll LL, Hurlbut KM, eds. POISINDEX System. Greenwood Village, Colo.: Micromedex; Vol. 119.

Cited by

See all 103

Related

See all

Metadata

Authors
Smith, K. M., & Romanelli, F.
Affiliations
University of Kentucky (US)
Corresponding author
Smith, Kelly M.
ORCID
Venue
Journal of the American Pharmacists Association
Publisher
Elsevier BV
Published
2005-01
Volume
45
Issue
1
Pages
63-75
ISSN
1544-3191 (ISSN-L)
DOI
10.1331/1544345052843165
OpenAlex
W1991880234
Semantic Scholar
572e5bf90626970d5a11fb962d281ad884bda98e
Cited by
103
References
40
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 11 · 2018: 2 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 5
FWCI
8.83
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the American Pharmacists Association (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
phosphodiesterase-5 inhibitors, sildenafil, tadalafil, vardenafil, recreational drug use, drug abuse, erectile dysfunction, cardiovascular adverse events, drug interactions, club drugs, ketamine, amyl nitrite, HIV, pharmacist counseling
MeSH terms
Attitude to Health, Clinical Trials as Topic, Decision Making, Humans, Legislation, Medical, Registries, Societies, Pharmaceutical, State Government, United States, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Access to Information, Disclosure, Judicial Role

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recreational Use and Misuse of Phosphodiesterase 5 Inhibitors. https://app.cochat.ai/papers/10.1331/1544345052843165
The paper
Smith, K. M., & Romanelli, F. (2005). Recreational Use and Misuse of Phosphodiesterase 5 Inhibitors. Journal of the American Pharmacists Association. https://doi.org/10.1331/1544345052843165

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.